Literature DB >> 2415715

Molecular analysis of several classes of endogenous feline leukemia virus elements.

L H Soe, R W Shimizu, J R Landolph, P Roy-Burman.   

Abstract

Five recombinant DNA clones of endogenous feline leukemia virus-related DNA sequences were isolated by screening a lambda phage genomic library of cat placental DNA with a probe specific to the gag-pol region of infectious feline leukemia virus. The clones containing retroviral long terminal repeat-like sequences demonstrated the existence of different size classes of endogenous elements in the cat genome, including those of nearly full length in which the gag region is heterogeneous but all of pol and most of env are highly conserved. Other size classes included elements with major deletions in gag or pol. A genomic DNA analysis suggested that the majority of endogenous elements were close to full length in size and that the highly truncated sequences which we described previously (Soe et al., J. Virol. 46:829-840, 1983) represented only a subset of the elements present. A restriction analysis of genomic DNA suggested a high degree of conservation in pol and the 5' portion of env among the various endogenous sequences present in the cat genome. We also found by using DNA transfection that while all of the endogenous clones were noninfectious, there was differential expression of the elements which we examined. These findings correlate with the subgenomic expression of endogenous feline leukemia virus sequences in cat placental tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415715      PMCID: PMC252639     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Phosphoproteins: structural components of oncornaviruses.

Authors:  B K Pal; P Roy-Burman
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

2.  Homologies among the nucleotide sequences of the genomes of C-type viruses.

Authors:  N Quintrell; H E Varmus; J M Bishop; M O Nicholson; R M McAllister
Journal:  Virology       Date:  1974-04       Impact factor: 3.616

3.  Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests.

Authors:  P S Sarma; T Log
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

4.  Partial characterization of RD114 virus by DNA-RNA hybridization studies.

Authors:  M A Baluda; P Roy-Burman
Journal:  Nat New Biol       Date:  1973-07-11

5.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

6.  Horizontal transmission of leukemia virus and leukemia in the cat.

Authors:  W Jarrett; O Jarrett; L Mackey; H Laird; W Hardy; M Essex
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

7.  Horizontal transmission of feline leukaemia virus.

Authors:  W D Hardy; L J Old; P W Hess; M Essex; S Cotter
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

8.  Distribution of three classes of endogenous type-C RNA viruses among inbred strains of mice.

Authors:  J R Stephension; R K Reynolds; S R Tronick; S A Aaronson
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

9.  Evolution of type C viral genes: origin of feline leukemia virus.

Authors:  R E Benveniste; C J Sherr; G J Todaro
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

10.  Genetic analysis of the feline RD-114 retrovirus-related endogenous elements.

Authors:  D A Spodick; L H Soe; P Roy-Burman
Journal:  Virus Res       Date:  1984-10       Impact factor: 3.303

View more
  16 in total

1.  Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.

Authors:  S K Ghosh; P Roy-Burman; D V Faller
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Molecular cloning of an endogenous cat retroviral element (ECE 1)--a recombinant between RD-114 and FeLV-related sequences. Brief report.

Authors:  W Beyer; R Möhring; B Drescher; U Nötzel; S Rosenthal
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Detection of severe fever with thrombocytopenia syndrome virus and other viruses in cats via unbiased next-generation sequencing.

Authors:  Yasuyuki Momoi; Aya Matsuu
Journal:  J Vet Diagn Invest       Date:  2020-10-21       Impact factor: 1.279

4.  Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

Authors:  S K Ghosh; D V Faller
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus.

Authors:  D V Kumar; B T Berry; P Roy-Burman
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions.

Authors:  B T Berry; A K Ghosh; D V Kumar; D A Spodick; P Roy-Burman
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

7.  Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.

Authors:  M M Anderson; A S Lauring; S Robertson; C Dirks; J Overbaugh
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 8.  Endogenous env elements: partners in generation of pathogenic feline leukemia viruses.

Authors:  P Roy-Burman
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

9.  Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.

Authors:  R Pandey; A K Ghosh; D V Kumar; B A Bachman; D Shibata; P Roy-Burman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas.

Authors:  R L Sheets; R Pandey; W C Jen; P Roy-Burman
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.